WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

The Cannabis Regulatory Agency found medium chain triglyceride (MCT) oil, a prohibited ingredient, in Platinum brand vaping ...

The US FDA has approved the first clinical trials for pig kidney transplants in humans. According to the organisation, two biotechnology firms—United Therapeutics and eGenesis—will test genetically ...

The U.S. Senate has confirmed about half of President Donald Trump's picks for his cabinet so far. Here are Trump's choices for some key posts. PETE ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction problems unlike existing opioids.